Gatifloxacin Pharmacokinetics/Pharmacodynamics-based Optimal Dosing for Pulmonary and Meningeal Multidrug-resistant Tuberculosis
<br><strong>Background: </strong>Gatifloxacin is used for the treatment of multidrug-resistant tuberculosis (MDR-TB). The optimal dose is unknown.</br> <br><strong>Methods: </strong>We performed a 28-day gatifloxacin hollow-fiber system model of tuberculosi...
| Huvudupphovsmän: | , , , , , , , , , , , , |
|---|---|
| Materialtyp: | Journal article |
| Språk: | English |
| Publicerad: |
Oxford University Press
2018
|